A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate

Recombinant vaccines have low-cost manufacturing, regulatory requirements, and reduced side effects compared to attenuated or inactivated vaccines. In the porcine industry, post-weaning multisystemic disease syndrome generates economic losses, characterized by progressive weight loss and weakness in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamazares, Emilio, Gutiérrez, Fernando, Hidalgo, Angela, Gutiérrez, Nicolas A., Espinoza, Felipe I., Sánchez, Oliberto, Cortez-San Martín, Marcelo, Mascayano, Carolina, González, Javier, Saavedra, José, Altamirano, Claudia, Mansur, Manuel, Ruiz, Álvaro, Toledo, Jorge R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232224/
https://www.ncbi.nlm.nih.gov/pubmed/32244384
http://dx.doi.org/10.3390/v12040385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232224/
https://www.ncbi.nlm.nih.gov/pubmed/32244384
http://dx.doi.org/10.3390/v12040385

Ejemplares similares